Meeting
2011 Breast Cancer Symposium
Factors associated with mortality after breast cancer metastasis.
Authors
S. Y. Jung
Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA
S. Y. Jung , M. Q. Rosenzweig , S. M. Sereika , F. Linkov , A. Brufsky , J. L. Weissfeld
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C
Track
Prevention, Survivorship & Health Policy
Sub Track
Epidemiology
Citation
J Clin Oncol 29, 2011 (suppl 27; abstr 174)
Abstract #
174
Poster Bd #
B9
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Discordant ER, PR, and HER2 status between primary and metastatic breast cancer as prognostic factor.
First Author: Hee-Chul Shin
Poster
2022 ASCO Annual Meeting
ESR1 mutations in circulating tumor DNA (ctDNA) are associated with CTCs and increased hormone receptors in metastatic tumor tissues of patients with metastatic breast cancer (MBC).
First Author: Qiang Zhang
Poster
2021 ASCO Annual Meeting
Trends in breast cancer mortality according to molecular subtypes: A population-based study.
First Author: Yunan Han
Poster
2019 ASCO Annual Meeting
mTORC1 activation assessed in metastatic sample to predict outcome in patients with metastatic breast cancer treated with everolimus-exemestan: Results from the SAFIRTOR study.
First Author: Thomas Denis Bachelot